160 related articles for article (PubMed ID: 3535018)
1. The role of colloidal bismuth subcitrate in gastric ulcer and gastritis.
Tytgat GN; Rauws E; Langenberg W
Scand J Gastroenterol Suppl; 1986; 122():22-9. PubMed ID: 3535018
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
3. Bismuth: effects on gastritis and peptic ulcer.
Rokkas T; Sladen GE
Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
5. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study.
Kang JY; Tay HH; Wee A; Guan R; Math MV; Yap I
Gut; 1990 Apr; 31(4):476-80. PubMed ID: 2186982
[TBL] [Abstract][Full Text] [Related]
6. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
7. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate.
Loffeld RJ; Potters HV; Stobberingh E; Flendrig JA; van Spreeuwel JP; Arends JW
Gut; 1989 Sep; 30(9):1206-12. PubMed ID: 2680795
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
10. The role of colloidal bismuth subcitrate in the short-term treatment of duodenal ulcer.
Barbara L; Corinaldesi R; Rea E; Paternicò A; Stanghellini V
Scand J Gastroenterol Suppl; 1986; 122():30-4. PubMed ID: 3535019
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration.
Tytgat GN; van Bentem N; van Olffen G; Dekker W; Rutgeerts L; de Boer J
Scand J Gastroenterol Suppl; 1982; 80():31-8. PubMed ID: 6761850
[No Abstract] [Full Text] [Related]
12. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia.
Vaira D; Holton J; Ainley C; Falzon M; Osborn J; D'Anna L; Romanos A; Chandrakumaran K; McNeil I
Ital J Gastroenterol; 1992 Sep; 24(7):400-4. PubMed ID: 1392023
[TBL] [Abstract][Full Text] [Related]
13. Review of the modes of action of colloidal bismuth subcitrate.
Hall DW
Scand J Gastroenterol Suppl; 1989; 157():3-6; discussion 21-2. PubMed ID: 2665050
[TBL] [Abstract][Full Text] [Related]
14. Campylobacter pyloridis and gastritis.
Marshall BJ
J Infect Dis; 1986 Apr; 153(4):650-7. PubMed ID: 3512736
[No Abstract] [Full Text] [Related]
15. Colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN
S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.
Glupczynski Y; Burette A; Nyst JF; De Prez C; De Koster E; Deltenre M
Acta Gastroenterol Belg; 1988; 51(4-5):329-37. PubMed ID: 2979039
[TBL] [Abstract][Full Text] [Related]
17. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
Menge H
Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
[No Abstract] [Full Text] [Related]
18. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.
Rauws EA; Langenberg W; Houthoff HJ; Zanen HC; Tytgat GN
Gastroenterology; 1988 Jan; 94(1):33-40. PubMed ID: 3335295
[TBL] [Abstract][Full Text] [Related]
19. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.
Marshall BJ; Goodwin CS; Warren JR; Murray R; Blincow ED; Blackbourn SJ; Phillips M; Waters TE; Sanderson CR
Lancet; 1988 Dec 24-31; 2(8626-8627):1437-42. PubMed ID: 2904568
[TBL] [Abstract][Full Text] [Related]
20. Recent experimental and clinical studies on the pharmacology of colloidal bismuth subcitrate.
Elder JB
Scand J Gastroenterol Suppl; 1986; 122():14-6. PubMed ID: 3535016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
